Sep 05, 2025
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology
Aug 05, 2025
SOPHiA GENETICS Reports Second Quarter 2025 Results
Aug 05, 2025
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
Jul 22, 2025
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025
May 06, 2025
SOPHiA GENETICS Reports First Quarter 2025 Results
Apr 28, 2025
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
Apr 22, 2025
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025
Mar 18, 2025
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
Jan 28, 2025
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
Nov 21, 2024
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM(TM) at AMP 2024
Nov 05, 2024
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
Nov 05, 2024
SOPHiA GENETICS Reports Third Quarter 2024 Results
Oct 22, 2024
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024
Sep 14, 2024
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024
Sep 12, 2024
SOPHiA GENETICS Announces Poster Presentations at ESMO 2024
Sep 12, 2024
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
Sep 10, 2024
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
Sep 05, 2024
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024
Aug 28, 2024
SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference
Aug 14, 2024
SOPHiA DDM(TM) Platform Certified Under IVDR